Hepatitis viral status in patients undergoing liver resection for hepatocellular carcinoma

British Journal of Surgery

Volumn 86, Issue 11, 1999, Pages 1391-1396

  Wu, C C ^a,b   Ho, W L ^a   Chen, J T ^a   Tang, J S ^b   Yeh, D C ^b   P'eng, F K ^b  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; EPIRUBICIN; FLUOROURACIL; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; FEMALE; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER FUNCTION; LIVER METASTASIS; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PATHOLOGY; PATIENT SELECTION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SERODIAGNOSIS; SURGICAL MORTALITY; SURGICAL RISK; VIRUS HEPATITIS;

AGED; CARCINOMA, HEPATOCELLULAR; DISEASE-FREE SURVIVAL; FEMALE; HEPATITIS B SURFACE ANTIGENS; HEPATITIS C ANTIBODIES; HUMANS; INTRAOPERATIVE CARE; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RETROSPECTIVE STUDIES; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 0032697194     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2168.1999.01272.x     Document Type: Article

References (20)

1. 1 Okuda K. Hepatitis C virus and hepatocellular carcinoma. In: Okuda K, Tabor E, eds. Liver Cancer. New York: Churchill Livingstone, 1997: 39-50.
2. 2 Sherlock S. Viruses and hepatocellular carcinoma. Gut 1994; 35: 828-32.
3. 3 Chen P-J, Chen D-S. Hepatitis B virus and hepatocellular carcinoma. In: Okuda K, Tabor E, eds. Liver Cancer. New York: Churchill Livingstone, 1997: 29-37.
4. 4 Beasley RP, Hwang L-Y, Lin C-C, Chen C-S. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan. Lancet 1981; ii: 1129-32.
5. 5 Chen D-S, Kuo GC, Sung J-L, Lai M-Y, Sheu J-C, Chen P-J et al. Hepatitis C virus infection in an area hyperendemic for hepatitis B and chronic liver disease: the Taiwan experience. J Infect Dis 1990; 162: 817-22.
6. 6 Chuang W-L, Chang W-Y, Lu S-N, Su W-P, Lin Z-Y, Chen S-C et al. The role of hepatitis B and C viruses in hepatocellular carcinoma in a hepatitis B endemic area. A case-control study. Cancer 1992; 69: 2052-4.
7. 7 Lee S-D, Lee F-Y, Wu J-C, Hwang S-J, Wang S-S, Lo K-J. The prevalence of anti-hepatitis C virus among Chinese patients with hepatocellular carcinoma. Cancer 1992; 69: 342-5.
8. 8 Chen M-F, Jeng L-B, Lee W-C, Chen T-C. Surgical results in patients with dual hepatitis B- and C-related hepatocellular carcinoma compared with hepatitis B- or C-related hepatocellular carcinoma. Surgery 1998; 123: 554-9.
9. 9 Akriviadis EA, Llovet JM, Efremidis SC, Shouval D, Canelo R, Ringe B et al. Hepatocellular carcinoma. Br J Surg 1998; 85: 1319-31.
10. 10 Shiratori Y, Shiina S, Imamura M, Kato N, Kanai F, Okudaira T et al. Characteristic difference of hepato-cellular carcinoma between hepatitis B- and C-viral infection in Japan. Hepatology 1995; 22: 1027-33.
11. 11 Miyagawa S, Kawasaki S, Makuuchi M. Comparison of the characteristics of hepatocellular carcinoma between hepatitis B and C viral infection: tumor multicentricity in cirrhotic liver with hepatitis C. Hepatology 1996; 24: 307-10.
12. 12 Yamanaka N, Tanaka T, Tanaka W, Yamanaka J, Yasui C, Kuroda N et al. Correlation of hepatitis viral status with clinicopathologic features in patients undergoing hepatectomy for hepatocellular carcinoma. Cancer 1997; 79: 1509-15.
13. 13 Shiraishi M, Hiroyasu S, Nagahama M, Tomita S, Miyahira T, Kusano T et al. Characteristics of hepatocellular carcinoma in patients with negative virus markers: clinicopathologic study of resected tumours. World J Surg 1999; 23: 301-5.
14. 14 Haratake J, Takeda S, Kasai T, Nakano S, Tokui N. Predictable factors for estimating prognosis of patients after resection of hepatocellular carcinoma. Cancer 1993; 72: 1178-83.
15. 15 Takenaka K, Yamamoto K, Taketomi A, Itasaka H, Adachi E, Shirabe K et al. A comparison of the surgical results in patients with hepatitis B versus hepatitis C-related hepatocellular carcinoma. Hepatology 1995; 22: 20-4.
16. 16 Wu C-C, Ho W-L, Yeh D-C, Huang C-R, Liu T-J, P'eng F-K. Hepatic resection of hepatocellular carcinoma in cirrhotic livers: is it unjustified in impaired liver function? Surgery 1996; 120: 34-9.
17. 17 Wu C-C, Ho W-L, Lin M-C, Yeh D-C, Wu H-S, Hwang C-J et al. Hepatic resection for bilobar multicentric hepatocellular carcinoma: is it justified? Surgery 1998; 123: 270-7.
18. 18 Wu C-C, Chen J-T, Ho W-L, Yeh D-C, Tang J-S, Liu T-J et al. Liver resection for hepatocellular carcinoma in octogenarians. Surgery 1999; 125: 332-8.
19. 19 Couinaud C. Lobes et segments hépatiques: notes sur l'architecture anatomique et chirugicale de foie. Presse Med 1954; 62: 709-12.
20. 20 Sobin LH, Wittekind C, eds. TNM Classification of Malignant Tumours. 5th ed. New York: Wiley-Liss, 1997.